
Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc.(INBX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
inbx · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$325
Consensus
$325
+264.3% upside
Low
$325
Median: $325 · Last Close: $89.21
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $84.75 | ↓ 5.00% |
1-day model range: $83.86–$85.63. Peak: $85.63 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · INBX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-22 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2025-05-15 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2025-03-18 | Citizens Capital Markets | Maintains | Market Perform→Market Perform |
| 2025-01-22 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2024-01-23 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2023-11-20 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-08-23 | JMP Securities | Maintains | Outperform→Outperform |
| 2023-05-10 | JMP Securities | Maintains | Market Outperform→Outperform |
| 2023-03-08 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-03-07 | Credit Suisse | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Inhibrx Biosciences, Inc. (INBX) stock. Of the recent 19 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover INBX.
分析师推荐趋势
INBX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$4M
↓ 96.7% YoY
Revenue Next Year
$57M
↑ 1230.2% YoY
EPS This Year
$-9.23
EPS Next Year
$-6.53
↓ 29.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast INBX EPS of $-9.23 for the current fiscal year, based on estimates from 1 analysts. The INBX revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
INBX 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。INBX 的共识目标价为 $325.00(+264.3% 上行空间),分析师共识为 Buy。
INBX 的短期预测(明日)为 $84.75(-5.00%)。
Inhibrx Biosciences, Inc. 在 NASDAQ 上市,代码 INBX。INBX 在 2027 年的整体展望偏积极,在覆盖分析师中约 60% 对应 Buy 共识。
常见问题
INBX 预测 · 8 个问题根据 5 位华尔街分析师,INBX 的 12 个月平均目标价为 $325.00,最高 $325.00、最低 $325.00。若有图表,中位目标价可在上方查看。相对当前价 $89.21,隐含约 +264.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.